GHK-Cu Dosing Protocol & Schedule GHK-Cu is researched through two very different routes: subcutaneous injection of a reconstituted vial and topical application of a cream, serum, or microneedling-adjacent formulation
Following Bonferronis correction for 197 detected metabolites, NAC treatment significantly reduced Kyn levels relative to placebo (raw p = 2.8 10 7 , FDR corrected p = 6.6 10 5 )
The newly formed abGCs are excitatory neurons with a characteristic set of functional properties including enhanced plasticity (Schmidt-Hieber et al., 2004)
Any vendor whose COA falls outside the standard purity range, lists a different molecular weight than the compound spec, or fails to identify the testing lab should be treated with extra scrutiny
Reduces Drug Toxicity BPC-157 may protect against the toxic effects of certain drugs, such as neuroleptics, alcohol, NSAIDs, and insulin